Literature DB >> 1590494

A crossover study of focused cognitive therapy for panic disorder.

A T Beck1, L Sokol, D A Clark, R Berchick, F Wright.   

Abstract

OBJECTIVE: This study sought to determine the short- and long-term effects of focused cognitive therapy for panic disorder.
METHOD: Thirty-three psychiatric outpatients with the DSM-III diagnosis of panic disorder were randomly assigned to either 12 weeks of individual, focused cognitive therapy or 8 weeks of brief supportive psychotherapy based on principles of client-centered therapy. The patients who received supportive psychotherapy were subsequently given the opportunity to cross over to cognitive therapy for 12 weeks. Patients were rated for panic and depression before therapy, after 4 and 8 weeks of therapy, and at 6-month and 1-year follow-up.
RESULTS: Clinician ratings and self-ratings of panic frequency and intensity indicated that the focused cognitive therapy group achieved significantly greater reductions in panic symptoms and general anxiety after 8 weeks of treatment than did the group that received brief supportive psychotherapy. At 8 weeks, 71% of the cognitive therapy group were panic free, compared to 25% of the psychotherapy group. Moreover, 94% of the psychotherapy patients elected to cross over to 12 weeks of cognitive therapy. At 1-year follow-up, 87% of the group that received cognitive therapy only and 79% of the group that crossed over into cognitive therapy remained free of panic attacks.
CONCLUSIONS: Focused cognitive therapy offers a promising nonpharmacological alternative for the treatment of panic disorder.

Entities:  

Mesh:

Year:  1992        PMID: 1590494     DOI: 10.1176/ajp.149.6.778

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  10 in total

1.  Talk that works: the rise of cognitive behaviour therapy.

Authors:  G Andrews
Journal:  BMJ       Date:  1996-12-14

2.  Can psychotherapists function as their own controls? Meta-analysis of the crossed therapist design in comparative psychotherapy trials.

Authors:  Fredrik Falkenström; John C Markowitz; Hanske Jonker; Björn Philips; Rolf Holmqvist
Journal:  J Clin Psychiatry       Date:  2012-10-30       Impact factor: 4.384

3.  Clinical and economic evaluation of benzodiazepines: a value analysis.

Authors:  J S Lyons; D B Larson; J Hromco
Journal:  Pharmacoeconomics       Date:  1992-11       Impact factor: 4.981

Review 4.  Cognitive-behavioral therapy for panic: effectiveness and limitations.

Authors:  C Goldberg
Journal:  Psychiatr Q       Date:  1998

Review 5.  Diagnosis and management of panic disorder in older patients.

Authors:  Alastair J Flint; Nadine Gagnon
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

Review 6.  Diagnosis and treatment of agoraphobia with panic disorder.

Authors:  Giulio Perugi; Franco Frare; Cristina Toni
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

7.  Nonpharmacological treatments for anxiety disorders.

Authors:  Jean Cottraux
Journal:  Dialogues Clin Neurosci       Date:  2002-09       Impact factor: 5.986

Review 8.  Psychological therapies for panic disorder with or without agoraphobia in adults: a network meta-analysis.

Authors:  Alessandro Pompoli; Toshi A Furukawa; Hissei Imai; Aran Tajika; Orestis Efthimiou; Georgia Salanti
Journal:  Cochrane Database Syst Rev       Date:  2016-04-13

Review 9.  Combination of psychotherapy and benzodiazepines versus either therapy alone for panic disorder: a systematic review.

Authors:  Norio Watanabe; Rachel Churchill; Toshi A Furukawa
Journal:  BMC Psychiatry       Date:  2007-05-14       Impact factor: 3.630

10.  Three year naturalistic outcome study of panic disorder patients treated with paroxetine.

Authors:  Pinhas N Dannon; Iulian Iancu; Ami Cohen; Katherine Lowengrub; Leon Grunhaus; Moshe Kotler
Journal:  BMC Psychiatry       Date:  2004-06-11       Impact factor: 3.630

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.